MB "Klaipėdos endobiogenika" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
0 |
0 |
0 |
0 |
2023 |
---|
1,494 |
- |
-3,093 |
-3,093 |
- |
-169.34 |
-207.03 |
-2,693 |
2,693 |
0 |
0 |
2024 |
---|
4,214 |
- |
-2,813 |
-2,813 |
- |
-20.84 |
-66.75 |
-5,506 |
6,559 |
0 |
1,053 |
Register and
explore Okredo data2024 |
---|
4,214 |
- |
-2,813 |
-2,813 |
- |
-20.84 |
-66.75 |
-5,506 |
6,559 |
0 |
1,053 |
Register and
explore Okredo data2024
Turnover (€)
4,214 €182 % *
Sales per employee (€)
-Profit before tax (€)
-2,813 €9 % *
Net Profit (€)
-2,813 €9 % *
Profit per employee (€)
-Total profitability (%)
-20.84 %87.69 % *
Net profitability (%)
-66.75 %67.76 % *
Equity (€)
-5,506 €-104 % *
Amounts Payable And Liabilities (€)
6,559 €144 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
1,053 €- *